Sign Up to like & get
recommendations!
0
Published in 2021 at "Metabolism: clinical and experimental"
DOI: 10.1016/j.metabol.2021.154801
Abstract: OBJECTIVE NAFLD is a complex disease marked by cellular abnormalities leading to NASH. NAFLD patients manifest low hepatic levels of CEACAM1, a promoter of insulin clearance. Consistently, Cc1-/- null mice displayed spontaneous hyperinsulinemia/insulin resistance and…
read more here.
Keywords:
fibrosis;
fibrosis carcinoembryonic;
hepatic fibrosis;
regulation hepatic ... See more keywords